Scarica l'app Stockscreener
14.78
4.34%
-0.67
Dopo l'orario di chiusura:
14.95
0.17
+1.15%
Syndax Pharmaceuticals Inc Borsa (SNDX) Ultime notizie
Syndax Pharmaceuticals (NASDAQ:SNDX) Given "Buy" Rating at BTIG Research - MarketBeat
Highs Report: What’s next for IRIDEX Corporation stockBreakout Watch & Daily Profit Focused Stock Screening - khodrobank.com
Update Recap: Can CZWI disrupt its industryEarnings Recap Report & Verified Entry Point Signals - khodrobank.com
BTIG Reiterates Buy Rating on SNDX with $56 Price Target | SNDX Stock News - GuruFocus
3 Potential Biotech Acquisition Targets - Seeking Alpha
SNDX: Revumenib Gains Key NCCN Recommendation for AML Treatment - GuruFocus
Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia - The Manila Times
Syndax’s Revuforj® (revumenib) Included in NCCN Clinical - GlobeNewswire
Major Treatment Update: Syndax's Revuforj Secures NCCN Recognition for Rare Leukemia Mutation Therapy - Stock Titan
Breakouts Watch: Does Syndax Pharmaceuticals Inc. have strong fundamentalsPortfolio Value Report & Expert Curated Trade Ideas - khodrobank.com
Syndax resumed with Buy at Stifel on newly launched drugs - MSN
Syndax Pharmaceuticals’ SWOT analysis: biotech stock navigates AML market By Investing.com - Investing.com Canada
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 4.8%Time to Sell? - MarketBeat
Syndax Pharmaceuticals’ SWOT analysis: biotech stock navigates AML market - Investing.com
Risk Hedge: Is Syndax Pharmaceuticals Inc stock a top performer YTDJuly 2025 Technicals & Stepwise Swing Trade Plans - خودرو بانک
Fundamentals Check: Can L3Harris Technologies Inc deliver consistent EPS growthWeekly Risk Summary & Stock Portfolio Risk Control - خودرو بانک
Earnings Recap: What are the future prospects of Syndax Pharmaceuticals IncTrade Analysis Report & Real-Time Market Sentiment Alerts - khodrobank.com
Syndax Pharmaceuticals (NASDAQ:SNDX) Now Covered by Stifel Nicolaus - MarketBeat
Exome Asset Management LLC Increases Stake in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
213,159 Shares in Syndax Pharmaceuticals, Inc. $SNDX Acquired by Zimmer Partners LP - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) CEO Sells $2,581,407.87 in Stock - MarketBeat
Polar Asset Management Partners Inc. Has $1.31 Million Holdings in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals, Inc. $SNDX Shares Bought by Parkman Healthcare Partners LLC - MarketBeat
Syndax Pharmaceuticals: Revumenib PDUFA Review mNPM1 AML And Move Towards MSS CRC (SNDX) - Seeking Alpha
SNDX: Stifel Reinstates 'Buy' Rating with $44 Price Target | SND - GuruFocus
Syndax (SNDX) Gains "Buy" Rating from Stifel, Eyeing Major Growt - GuruFocus
Stifel Initiates Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Announces Target Price $44 - 富途牛牛
Stifel resumes Syndax Pharmaceuticals stock coverage with Buy rating By Investing.com - Investing.com Canada
Syndax Pharmaceuticals, Inc. $SNDX Shares Sold by Granahan Investment Management LLC - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Now Covered by Guggenheim - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Fibonacci Retracement Aligns with Support in Syndax Pharmaceuticals Inc.Options Play & Risk Managed Investment Signals - beatles.ru
Ieq Capital LLC Invests $727,000 in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals at H.C. Wainwright: Strategic Growth and Profitability By Investing.com - Investing.com Canada
Is Syndax Pharmaceuticals Inc. stock a value trapQuarterly Portfolio Report & Free Daily Entry Point Trade Alerts - beatles.ru
Invesco Ltd. Has $944,000 Stake in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Raised to $24.00 - Defense World
Is Syndax Pharmaceuticals Inc. stock forming a triangle patternLayoff News & Community Trade Idea Sharing - beatles.ru
Should I invest in Syndax Pharmaceuticals Inc. before earnings2025 Top Decliners & Stock Timing and Entry Methods - beatles.ru
Will Syndax Pharmaceuticals Inc. Benefit From Sector TailwindsWatch List & Daily Oversold Stock Bounce Ideas - beatles.ru
Syndax Pharmaceuticals Reports Inducement Grants Under - MSN
When Will Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Turn A Profit? - simplywall.st
Trexquant Investment LP Decreases Stock Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Point72 Europe London LLP Acquires Shares of 184,683 Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Wellington Management Group LLP Sells 4,198,493 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Why is Syndax Pharmaceuticals Inc. stock going downEarnings Growth Summary & Weekly Stock Performance Updates - خودرو بانک
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):